BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18600251)

  • 1. Reply to Drug Insight: antioxidant therapy in inherited ataxias.
    Gohil K; Azzi A
    Nat Clin Pract Neurol; 2008 Jul; 4(7):E1; author reply E2. PubMed ID: 18600251
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug Insight: antioxidant therapy in inherited ataxias.
    Pandolfo M
    Nat Clin Pract Neurol; 2008 Feb; 4(2):86-96. PubMed ID: 18256680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ataxia with vitamin E deficiency: biochemical effects of malcompliance with vitamin E therapy.
    Schuelke M; Finckh B; Sistermans EA; Ausems MG; Hübner C; von Moers A
    Neurology; 2000 Nov; 55(10):1584-6. PubMed ID: 11094124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Charting the effects of antioxidant therapy in the diseased brain: focus on "vitamin E deficiency and metabolic deficits in neuronal ceroid lipofuscinosis described by bioinformatics".
    Järvelä I; Glueck SB
    Physiol Genomics; 2002 Dec; 11(3):183-4. PubMed ID: 12464692
    [No Abstract]   [Full Text] [Related]  

  • 5. Hereditary vitamin-E deficiency.
    Gordon N
    Dev Med Child Neurol; 2001 Feb; 43(2):133-5. PubMed ID: 11221903
    [No Abstract]   [Full Text] [Related]  

  • 6. A rational approach to antioxidant therapy and vitamin E.
    Hyman M; Pizzorno J; Weil A
    Altern Ther Health Med; 2005; 11(1):14-7. PubMed ID: 15712759
    [No Abstract]   [Full Text] [Related]  

  • 7. [An antioxidant in pediatrics].
    Gomirato G; Nigro N
    Minerva Pediatr; 1996; 48(7-8):321-4. PubMed ID: 8965763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic developments in chronic ataxias].
    Buompadre MC
    Medicina (B Aires); 2013; 73 Suppl 1():49-54. PubMed ID: 24072051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical consequences of heritable mutations in the alpha-tocopherol transfer protein.
    Qian J; Atkinson J; Manor D
    Biochemistry; 2006 Jul; 45(27):8236-42. PubMed ID: 16819822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ataxia with vitamin E deficiency in southeast Norway, case report.
    Koht J; Bjørnarå KA; Jørum E; Tallaksen CM
    Acta Neurol Scand Suppl; 2009; (189):42-5. PubMed ID: 19566498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of vitamin E treatment on progressive cognitive impairment in a patient with adult-onset ataxia: a case report.
    Takahashi T; Murata T; Kosaka H; Wada Y; Yoneda M
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):150-2. PubMed ID: 18773933
    [No Abstract]   [Full Text] [Related]  

  • 12. Ataxia with vitamin E deficiency (AVED); an example of the contribution of research in molecular genetic to counselling in Morocco.
    Bellayou H; Dehbi H; Bourezgui M; Slassi I; Nadifi S
    Pathol Biol (Paris); 2009 Jul; 57(5):425-6. PubMed ID: 19038506
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacious vitamin E treatment in a child with ataxia with isolated vitamin E deficiency.
    Doria-Lamba L; De Grandis E; Cristiani E; Fiocchi I; Montaldi L; Grosso P; Gellera C
    Eur J Pediatr; 2006 Jul; 165(7):494-5. PubMed ID: 16491382
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ataxia due to vitamin E deficiency].
    Gjerde IO; Storstein A; Skeie GO; Wester K; Hegrestad S; Houge G
    Tidsskr Nor Laegeforen; 1998 Aug; 118(20):3126-8. PubMed ID: 9760855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First Recognized Patient with Genetic Vitamin E Deficiency Stable after 36 Years of Controlled Supplement Therapy.
    Kohlschütter A; Finckh B; Nickel M; Bley A; Hübner C
    Neurodegener Dis; 2020; 20(1):35-38. PubMed ID: 32623435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomics in prevention of diabetic cardiovascular disease: utilization of the haptoglobin genotype in determining benefit from vitamin E.
    Levy AP; Blum S
    Expert Rev Cardiovasc Ther; 2007 Nov; 5(6):1105-11. PubMed ID: 18035926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjunctive vitamin E treatment in Wilson disease and suggestions for future trials.
    Shen L; Ji HF
    Hepatology; 2010 May; 51(5):1864; author reply 1864-5. PubMed ID: 20432273
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of ataxia in isolated vitamin E deficiency caused by alpha-tocopherol transfer protein deficiency.
    Schuelke M; Mayatepek E; Inter M; Becker M; Pfeiffer E; Speer A; Hübner C; Finckh B
    J Pediatr; 1999 Feb; 134(2):240-4. PubMed ID: 9931538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial vitamin E deficiency: Multiorgan complications support the adverse role of oxidative stress.
    Trotta E; Bortolotti S; Fugazzotto G; Gellera C; Montagnese S; Amodio P
    Nutrition; 2019; 63-64():57-60. PubMed ID: 30933726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supplementation of curcumin and vitamin E enhances oxidative stress, but restores hepatic histoarchitecture in hypothyroid rats.
    Subudhi U; Das K; Paital B; Bhanja S; Chainy GB
    Life Sci; 2009 Mar; 84(11-12):372-9. PubMed ID: 19174171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.